BGCS Thursday 5 th July. Time Session Location 7:30-9:30 Registration. Cervical Cancer Control in the UK now and in the future

Transcription

1 Thursday 5 th July 7:30-9:30 Registration 8:35-9:20 Dynamic Fluorescent Imaging In Gynaecological Oncology Surgery Meeting sponsored by Stryker Rutherford 8:35-9:20 Cervical Cancer Control in the UK now and in the future Meeting sponsored by MSD Wesley 9:30-9:40 Welcome and introduction Mr Tim Mould and Dr Rebecca Kristeleit Mountbatten 9:40-11:00 Surgical cancer techniques Mountbatten 9:40-10:00 10:00-10:20 10:20-10:40 10:40-11:00 Advanced surgical procedures for recurrent cancer Prof David Cibula, Charles University Hospital, Prague Should sentinel node procedures be used in every case of endometrial cancer? Dr Pernille Jensen, University of Southern Denmark Continent vs incontinent urinary diversion techniques Dr Nadeem Abu-Rustum, Memorial Sloan Kettering Surgical treatment of early cervical cancer minimal access or open? Dr Christina Fotopoulou, Imperial College Healthcare, London 11:00-11:30 Coffee break 11:30-13:00 Treating relapsed disease Mountbatten 11:30-11:50 11:50-12:10 12:10-12:30 12:30-12:50 12:50-13:00 Complete surgical resection in relapsed disease: Insights from desktop 3 Dr Andreas Du Bois, Kliniken Essen-Mitte Essen, Germany Why do ovarian cancers relapse? Dr James Brenton, Cancer Research UK Cambridge Institute Treatment of relapsed ovarian cancer Dr Rosalind Glasspool, University of Glasgow Genetic mutations guiding treatment Prof Chris Lord, Institute of Cancer Research Panel Discussion

2 Thursday 5 th July 13:00-14:10 Lunch and poster viewing Exhibition 13:05-14:05 Meeting sponsored by Roche Rutherford 14:10-15:10 NCRI session Mountbatten Session to be lead by Prof Iain McNeish 15:10-15:30 Mountbatten A randomised study for sentinel nodes in cervical cancer Dr Fabrice Lécuru, Chirurgie Cancérologique Gynécologique et du Sein 14:10-15:45 PARALLEL SESSION: Unit Leads Rutherford 14:10-14:30 Histopathology of borderline tumours Dr Naveena Singh, Barts Health NHS Trust, London 14:30-14:50 Surgical management of borderline tumours Prof Omer Devaja, Maidstone and Tunbridge Wells NHSFT 14:50-15:10 Tubal cancer screening Mr Adam Rosenthal, University College London Hospital 15:10-15:30 15:30-15:45 Uterine transplant in endometrial cancer Mr Richard Smith, Imperial College Healthcare NHS Trust, London Results of a BGCS Cancer Unit Lea Clinician Survey Mr Partha Sengupta, University Hospital of North Durham 15:30-16:00 Coffee break and poster viewing Exhibition 16:00-17:10 Tumours with poor response to standard systemic therapies Mountbatten 16:00-16:20 Targeting HPV in gynaecological cancers Dr Rowan Miller, University College London Hospital 16:20-16:40 16:40-17:10 Metastatic granulosa cell tumours Prof Isabelle Ray-Coquard, CLCC Léon Bérard, France Low grade ovarian cancer clinical and molecular aspects Dr Douglas Levine, NYU Langone Medical Center 17:15-18:15 British Gynaecological Cancer Society AGM Mountbatten End of day 1 19:00-00:00 Conference dinner (tickets must be booked in advance)

3 Friday 6 th July 7:30-8:50 Registration 8:30-9:15 Retroperitoneal anatomy and presentation of complex surgical cases Meeting sponsored by Medtronic Burns 8:30-9:15 How to integrate PARP inhibitor maintenance treatment into clinical practice Meeting sponsored by Tesaro Wesley 9:15-10:35 New opportunities for therapies Mountbatten 9:15-9:35 9:35-9:55 9:55-10:15 10:15-10:35 Micro satellite instability practical applications in treatment Dr Yvette Drew, Northern Institute of Cancer Research, Newcastle Should HIPEC be part of standard care in the UK? Dr Ranjit Manchandra, Barts Health NHS Trust DNA damage modulators and radiosensitisation Prof Anthony Chalmers, University of Glasgow Combining PARP and anti-angiogenesis in gynaecological cancers Dr Isabelle Ray-Coquard, CLCC Léon Bérard, France 10:35-11:10 Coffee break and poster viewing Exhibition 11:10-12:20 Proffered papers Mountbatten x proffered papers to be presented 12:20-13:40 Lunch and poster viewing Exhibition 12:30-13:30 What s your perspective on PARP inhibitors? Meeting sponsored by AstraZeneca Rutherford

4 Friday 6 th July 13:40-15:00 Prevention of malignancy Mountbatten 13:40-14:00 14:00-14:20 14:20-14:40 14:40-15:00 Aspirin for cancer prevention Prof Ruth Langley, MRC Clinical Trials Unit at University College London STIC and telomeres Dr Naveena Singh, Barts Health NHS Trust, London Extended genetic testing and GYN cancer risk Dr Zoe Kemp, The Royal Marsden Hospital, London Early detection of tubo-ovarian cancer novel strategies Prof Martin Widschwendter, University College London 15:00-15:20 Coffee break Exhibition 14:00-18: :00 PARALLEL SESSION (Invite only): Devising an evidence based patient information leaflet for extensive surgery for ovarian cancer Breaking News Session SGO, ASCO, ESMO Treatment for early cervical cancer ESGO Guidelines for ovarian cancer Prof Jonathan Ledermann, University College London Hospital TBC Mountbatten 16: Final Thoughts Mountbatten 16:00-16:20 16:20-16:40 16:40-17:00 The Danish Model - Improving cancer survival in Denmark Dr Lene Lundvall, Copenhagen University Hospital Discrepancy of care across the UK Prof Sean Kehoe, University College Birmingham Presentation of prizes Mr Andy Nordin, BGCS President Close of conference Mountbatten

5 Time BGCS 2018 SCCOHT Symposium, WESLEY ROOM Thursday 5th July 09:30-09:45 Registration Pre-session networking Session Opening of the Small Cell Ovarian Cancer Hypercalcemic Type Symposium (SCCOHT) 10:00-10:15 Welcome and introduction to the Small Cell Ovarian Cancer Hypercalcemic Type Symposium (SCCOHT) Dr Marc Tischkowitz, University of Cambridge 10:15-10:45 Pathological Aspects of SCCOHT Prof Glenn McCluggage, Belfast Health and Social Care Trust 10:45-11:15 Unexpected role for Immuno-oncology in SCCOHT Dr Douglas Levine, NYU Langone Medical Center 11:15-11:45 Coffee break 11:45-13:15 Part 2 of the SCCOHT Symposium 11:45-12:15 Uncovering druggable vulnerabilities of SCCOHT through functional genetics Dr Sidong Huang, McGill University, Canada 12:15-12:45 De-BAFling the role of SMARCA4 mutations in SCCOHT development and the potential for therapeutic interventions Prof Bernard Weissman, University of North Carolina at Chapel Hill, USA 12:45-13:15 Solving the genetics of SCCOHT Prof William Foulkes, McGill University Health Centre, Canada Interviews with the speakers 13:45-14:45 Lunch 14:45-15:45 Closed doors meeting End of session

6 NFGON Symposium, RUTHERFORD ROOM - Friday 6 th July Time 09:00-09:30 Registration Session 09:30-09:40 Welcome to the NFGON Symposium Helen Mandeville, President NFGON and Gynaecology Oncology Clinical Nurse Specialist, Gateshead Health NHS Foundation Trust Sex and survivorship after gynaecological cancer Julia Pugh, Macmillan Clinical Nurse Specialist Christie NHS Foundation Trust Health and Well Being Events Anuska Randolph-Stevens, Macmillan Support Worker and PhD Researcher in Health Psychology The Royal Marsden NHS Foundation Trust and University of Surrey Coffee Patient initiated follow-up in gynaecological oncology Nafisa Patel, Gynaecology Oncology Clinical Nurse Specialist, University Hospitals of Leicester Using co-production to improve pre and post-operative care for women undergoing radical vulval surgery Julie Dodds, Macmillan Support Nurse, Gateshead Health NHS Foundation Trust Share your experiences Interactive Around the country Discussions End of symposium